Worldwide Sales of Electrocardiography (ECG) Telemetry Devices to Value US$ 5.72 Billion by 2033

According to a recent industry analysis by Fact.MR, a supplier of market research and competitive information, the global market for ECG telemetry devices is estimated to be worth US$ 2.65 billion in 2023 and will grow to US$ 5.72 billion by 2033.

The electrical activity of the heart is monitored and recorded using a device class called an ECG telemetry device. It operates by identifying and converting into waveforms the electrical impulses generated when heart tissue polarizes and depolarizes. This technique is frequently used to spot cardiac abnormalities and check how a drug or heart-controlling device is operating. The ECG telemetry device can detect myocardial ischemia and complex dysrhythmias.

Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8198

The market for electrocardiography (ECG) telemetry devices is boosting due to the increasing demand for home care monitoring devices, respective governments' intervention to provide quality medical devices at an affordable price, growing demand for miniature and telemetry devices, and the rapidly developing global healthcare industry.

Key Takeaways from Market Study

Global demand for ECG telemetry devices is expected to increase at a CAGR of 8% from 2023 to 2033.
Sales of resting ECG devices are expected to rise at a CAGR of 9% during the forecast period.
Demand for stress ECG devices is predicted to expand at a CAGR of 7% during the next 10 years.
China's market for ECG telemetry devices is predicted to expand at a CAGR of 12% during the projected period.

Winning Strategy

Key manufacturers of ECG telemetry devices are developing advanced portable and wireless ECG devices, and for that, they are highly investing in R&D activities. Such developments by the leading companies are expected to boost their revenue shares and market position.

CardioComm Solutions, Inc. received FDA authorization in February 2019 to use the GEM mobile ECG software as well as the HeartCheck CardiBeat handle head ECG device, which is used to monitor the heartbeat.
The first 12-lead, full-service at-home ECG system for use in decentralised clinical trials was made available by Philips in January 2022.
Competitive Landscape

More small- and mid-sized businesses are anticipated to enter the market in the coming years as a result of the growing emphasis on advanced product creation and the expanding use of technologies in healthcare.

The most portable and slimline personal ECG device "KardiaMobile Card" in the United States was introduced by AliveCor in February 2022. It is the only personal ECG that is portable enough to fit in a wallet and provides real-time heart health information whenever and wherever you need it.

Key Companies Profiled

Aerotel Medical Systems (1998) Ltd.
Cardiac Science Corporation
GE Healthcare; Medtronic, Inc.
Nihon Kohden Corporation
Philips Healthcare
Schaeffler AG (Schaeffler Group)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Siemens Healthineers
Welch Allyn, Inc.

Key Segments of ECG Telemetry Devices Industry Research

• By Product :
o Resting ECG Devices
o Stress ECG Devices
o Holter Monitors
o Event Monitoring Systems
o ECG Management Systems

• By Application :
o Arrhythmias
o Myocardial Ischemia and Infarction
o Pacemaker Monitoring

• End User :
o Home Healthcare
o Hospitals
o Clinics

• By Region :
o North America
o Latin America
o Europe
o East Asia
o South Asia & Oceania
o MEA

Furthermore, the demand for ECG telemetry devices will increase quickly during the forecast period due to the rapid technological developments in the modernization of healthcare practices and the rising research and development efforts in the medical sector.

North America and Europe are dominating marketplaces for ECG telemetry devices due to the presence of key market players. Asia Pacific is considered to be an emerging market for ECG telemetry devices due to rapid developments in healthcare facilities across the region.

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global ECG telemetry devices market, presenting historical demand data (2018-2022) and forecast statistics for the period of 2023-2033.

The study divulges essential insights on the market on the basis of product (resting ECG devices, stress ECG devices, Holter monitors, event monitoring systems, ECG management systems), application (arrhythmias, myocardial ischemia & infarction, pacemaker monitoring), and end user (home healthcare, hospitals, clinics), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).

Key Questions Covered in the ECG telemetry devices report

What is the projected value of the ECG telemetry devices in 2023?
At what rate will the global ECG telemetry devices grow until 2033?
Which are the factors propelling the growth in the ECG telemetry devices?
Which region is expected to lead in the global ECG telemetry devices during 2023 to 2033?
Which are the factors driving the ECG telemetry devices during the forecast period?
What is the expected market value of the ECG telemetry devices during the forecast period?

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8198?AS 

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR;

Fact.MR research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.

This release was published on openPR.